Please visit our MS learning channel on Youtube, which provides hundreds of topics from our education programs, that were video-recorded and archived here: www.youtube.com/msviewsandnews -- Be empowered with MS news by registering with us: www.register.msviewsandnews.org

joomla ecommerce template -- Scroll left side of this blog for needed resources. Also, use our 'search by topic' tool, to find specific information.

Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.

============================================================

Monday, October 19, 2015

Pharmaceutical Financial Assistance Programs

The information showing below is made possible by the National Multiple Sclerosis Society, in alphabetical srquence

If you are currently taking or considering starting on a multiple sclerosis (MS) medication, use the links below to review the various patient assistance programs that are available. If you are enrolled in a specific program, please check these sites periodically to ensure you have the most current information.
  • Ampyra (U.S.)

    Company: Acorda Therapeutics
    Usage in MS: Walking

  • Aubagio® (U.S.)

    Company: Genzyme, A Sanofi Company
    Usage in MS: Disease-Modifying Agent
    MS One to One                                                                                                                                                                                                   www.MSOnetoOne.com
    1-855-MSOne2One (1-855-676-6326)
  • Avonex® (U.S. and Canada)

    Company: Biogen
    Usage in MS: Disease-Modifying Agent
    Above MS, www.abovems.com or call 1-800-456-2255
  • Betaseron® (U.S. and Canada)

    Company: Bayer Healthcare Pharmaceuticals, Inc.
    Usage in MS: Disease-Modifying Agent
    BETASERON PATIENT ASSISTANCE PROGRAM                                                                                                                          1-800-788-1467                                                                                                                                                                          www.betaseron.com/betaplus/affordability                                                                                                                                          

  • BOTOX

    Company: Allergan, Inc.
    Usage in MS: Bladder Dysfunction|Spasticity in the Upper Limbs
    BOTOX Reimbursement Program 
    www.botox.com/
  • Copaxone® (U.S. and Canada)

    Company: Teva Neuroscience
    Usage in MS: Disease-Modifying Agent
    Shared Solutions®                                                                                                                                                                              1-800-887-8100                           www.sharedsolutions.com                                                                                                                                       
  • Extavia® (U.S. and Canada)

    Company: Novartis Pharmaceuticals Corp.
    Usage in MS: Disease-Modifying Agent
    EXTAVIA GO PROGRAM
    1-866-925-2333                                                                                                                                                                        http://www.extavia.com/


  • Gilenya (U.S.)

    Company: Novartis Pharmaceuticals Corp.
    Usage in MS: Disease-Modifying Agent
    Gilenya Go Program
    1-800-445-3692
    www.gilenya.com/c/ms-pill/go-program
  • Glatopa [generic equivalent of Copaxone 20mg]

    Company: Sandoz
    Usage in MS: Disease-Modifying Agent
  • H.P. Acthar® (Repository Corticotropin) (U.S.)

    Company: Questcor Pharmaceuticals, Inc.
    Usage in MS: Acute Exacerbations
    Web: www.actharmsrelapse.com for information about financial assistance                                                                               Phone: 1-888-435-2284
  • Lemtrada™

    Usage in MS: Disease-Modifying Agent
    Company: Genzyme
    Usage in MS: Disease-Modifying Agent
    MS One to One
    1- 855-MSOne2One (1-855-676-6326)
  • Novantrone (U.S. and Canada)

    Usage in MS: Disease-Modifying Agent
    None available at this time
  • Plegridy®

    Company: Biogen
    Usage in MS: Disease-Modifying Agent
    Above MS
    1-800-456-2255
    www.abovems.com
  • Rebif®

    Company: EMD Serono, Inc. and Pfizer, Inc.
    Usage in MS: Disease-Modifying Agent
     MS LifeLines                                                                         1-877-447-3243                                                                      www.mslifelines.com
  • Tecfidera® (U.S.) (teck-fi-DARE-ah)

    Company: Biogen
    Usage in MS: Disease-Modifying Agent
    Above MS
    1-800-456-2255
    www.abovems.com
  • Tysabri ® (formerly called Antegren)

    Company: Biogen
    Usage in MS: Disease-Modifying Agent
    Above MS
    1-800-456-2255
    www.abovems.com
The following nonprofit organizations also offer programs that may be able to help people who have insurance and still need help with the cost of their disease-modifying therapy:

.===================================

No comments: